James P. Crowley and Professor Erwin Loh About Caffeine and It’s Positive Effects
James P. Crowley, Professor of Medicine emeritus at Brown University, reposted Professor Erwin Loh’s post on LinkedIn:
“Caffeine appears to do the opposite of what you might think when it comes to the heart. Scientists have found that a cup of coffee a day actually protects the heart from atrial fibrillation – a condition that can lead to stroke and heart failure.
In the DECAF (Does Eliminating Coffee Avoid Fibrillation) trial, the researchers found that caffeine resulted in a 39% lower risk of recurrent AF events, compared to those who abstained – and they have a few theories as to why this might be the case.
“Coffee increases physical activity which is known to reduce AF,” said senior author Professor Gregory Marcus from the Division of Cardiology at UCSF.
“Caffeine is also a diuretic which could potentially reduce blood pressure and in turn lessen AF risk.
Several other ingredients in coffee also have anti-inflammatory properties that could have positive effects.””
Quoting Professor Erwin Loh’s post:
“Caffeine appears to do the opposite of what you might think when it comes to the heart. Scientists have found that a cup of coffee a day actually protects the heart from atrial fibrillation – a condition that can lead to stroke and heart failure.
In the DECAF (Does Eliminating Coffee Avoid Fibrillation) trial, the researchers found that caffeine resulted in a 39% lower risk of recurrent AF events, compared to those who abstained – and they have a few theories as to why this might be the case.
“Coffee increases physical activity which is known to reduce AF,” said senior author Professor Gregory Marcus from the Division of Cardiology at UCSF. “Caffeine is also a diuretic which could potentially reduce blood pressure and in turn lessen AF risk. Several other ingredients in coffee also have anti-inflammatory properties that could have positive effects.”
Title: Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation
Authors: Christopher X. Wong, Christopher C. Cheung, Gabrielle Montenegro, Hannah H. Oo, Isabella J. Peña, Janet J. Tang, Samuel J. Tu, Grace Wall, Thomas A. Dewland, Joshua D. Moss, Edward P. Gerstenfeld, Zian H. Tseng, Henry H. Hsia, Randall J. Lee, Jeffrey E. Olgin, Vasanth Vedantham, Melvin M. Scheinman, Catherine Lee, Prashanthan Sanders, Gregory M. Marcus

Read full article here.
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism